https://www.gosh.nhs.uk/news/chief-medical-officer-takes-up-new-role-at-barts-health/
Chief Medical Officer takes up new role at Barts Health
22 Nov 2024, noon
Professor Sanjiv Sharma will be leaving Great Ormond Street Hospital (GOSH) to take up the new role of Group Chief Medical Officer for Barts Health NHS Trust. He will take up the role in March 2025.
This appointment builds on his clinical leadership experience at GOSH and extends it across a group of five hospitals ranging from highly specialised tertiary services to community settings.
Sanjiv joined the Hospital in 2004 as registrar and became a substantive consultant intensivist in 2010. Since then has had various leadership roles at GOHS, including Specialty Lead, and then Deputy Medical Director and Chief Medical Officer. Most recently he has been our Deputy Chief Executive.
Matthew Shaw, CEO, said: “Sanjiv is a phenomenal leader and I am sure will thrive in this new role. As our Chief Medical Officer and more latterly Deputy Chief Executive, he has led a wide range of strategic programmes and transformation work. He has been a national advocate for specialist paediatric services and patient safety.
“I personally would like thank him for all he has done for the organisation and his decades of service to the children and young people at GOSH.”
Sanjiv said: “After being at GOSH for so many years and working towards supporting children’s health and care it is sad to be leaving but I am excited at the prospective of joining Barts Health.
"Here I hope to be able to use my experience to support patient care in an even larger and more broad setting. I have been lucky to have worked with so many talented people and great teams at GOSH and I look forward to being able to support them in a different way in the future.”
Our new strategy has launched: Together We Power Care
We’re proud to share our new Trust Strategy for Great Ormond Street Hospital for Children, TOGETHER WE POWER CARE. This is our vision for the future, and the steps we’ll take to achieve our ambitions of delivering life-changing care for our children.
GOSH contributes to landmark UAE-UK paper on AI in healthcare
We're proud to have contributed to a new paper published by the UAE-UK Business Council, exploring future opportunities for collaboration in artificial intelligence (AI) in healthcare between the United Kingdom and the United Arab Emirates.
Landmark gene therapy study shows safety for children
Results from the largest cohort of children who received a gene therapy for a rare immunodeficiency condition have shown the long-term safety and efficacy of the curative treatment.